Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, has announced that the U.S. Food and Drug Administration (FDA) has approved the enVista® Envy™ intraocular lens (IOL),…
VISIE Inc., formerly Advanced Scanners, has successfully showcased Continuous Anatomic Auto Tracking (CAAT) for robotic-assisted total knee arthroplasty (RA-TKA) at its headquarters in Austin, TX. Continuous Anatomic Auto Tracking (CAAT)…
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company known for its UroShield®, PainShield®, and WoundShield® Surface Acoustic Wave (SAW) portable ultrasonic therapeutic devices, has announced a non-binding term sheet for…
Amprion, a global leader in neurodegenerative disorder diagnostics, has announced the successful initial close of $6 million in its $15 million Series B financing round. The round was led by…
Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology firm focused on developing innovative small molecules for immune-mediated diseases, has announced that its Investigational New Drug (IND) application for zetomipzomib,…
Charles River Laboratories International, Inc. (NYSE: CRL) has announced that its neuroscience drug discovery team will present 18 scientific posters at Neuroscience 2024, the annual meeting of the Society for…
Synchron, a brain-computer interface company, has announced positive results from the COMMAND study, which assessed the safety and efficacy of its BCI device in six participants over a 12-month period.…
Henry Schein, Inc. (Nasdaq: HSIC) is reminding customers in Florida and areas expected to be impacted by Hurricane Helene that its Customer Assistance Hotline is available for dentists and physicians…
Baxter International Inc. (NYSE:BAX), a global leader in medical technology, has launched its next-generation airway clearance system, the Vest Advanced Pulmonary Experience (APX) System, at the North American Cystic Fibrosis…
Estrella Immunopharma, Inc. (Nasdaq: ESLA, ESLAW), a clinical-stage biopharmaceutical company specializing in ARTEMIS® T-cell therapies targeting CD19 and CD22 for cancer and autoimmune disease treatment, has announced that the first…
Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF) is pleased to announce its participation in the 2024 Association for Vascular Access (AVA) Annual Scientific Meeting, scheduled from September 28 to 30…
GE HealthCare (Nasdaq: GEHC) today unveiled its latest innovations in radiation oncology at the American Society for Radiation Oncology (ASTRO) 2024 conference in Washington, DC. These cutting-edge solutions are designed…